Literature DB >> 34936006

[German research groups are at the forefront in the application of innovative treatments of systemic lupus erythematosus].

Christof Specker1, Rebecca Fischer-Betz2, Andreas Krause3, Hendrik Schulze-Koops4.   

Abstract

Entities:  

Mesh：

Year:  2021        PMID： 34936006     DOI： 10.1007/s00393-021-01138-5

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN： 0340-1855            Impact factor:   1.372


× No keyword cloud information.
  5 in total

1.  Development and resolution of secondary autoimmunity after autologous haematopoietic stem cell transplantation for systemic lupus erythematosus: competition of plasma cells for survival niches?

Authors:  Tobias Alexander; Sandra Schneider; Bimba Hoyer; Qingyu Cheng; Andreas Thiel; Sabine Ziemer; Gerd-Rüdiger Burmester; Renate Arnold; Andreas Radbruch; Falk Hiepe
Journal:  Ann Rheum Dis       Date:  2013-01-29       Impact factor: 19.103

2.  Targeting CD38 with Daratumumab in Refractory Systemic Lupus Erythematosus.

Authors:  Lennard Ostendorf; Marie Burns; Pawel Durek; Gitta Anne Heinz; Frederik Heinrich; Panagiotis Garantziotis; Philipp Enghard; Ulrich Richter; Robert Biesen; Udo Schneider; Fabian Knebel; Gerd Burmester; Andreas Radbruch; Henrik E Mei; Mir-Farzin Mashreghi; Falk Hiepe; Tobias Alexander
Journal:  N Engl J Med       Date:  2020-09-17       Impact factor: 91.245

3.  Depletion of autoreactive immunologic memory followed by autologous hematopoietic stem cell transplantation in patients with refractory SLE induces long-term remission through de novo generation of a juvenile and tolerant immune system.

Authors:  Tobias Alexander; Andreas Thiel; Oliver Rosen; Gero Massenkeil; Arne Sattler; Siegfried Kohler; Henrik Mei; Hartmut Radtke; Erika Gromnica-Ihle; Gerd-Rüdiger Burmester; Renate Arnold; Andreas Radbruch; Falk Hiepe
Journal:  Blood       Date:  2008-09-29       Impact factor: 22.113

4.  CD19-Targeted CAR T Cells in Refractory Systemic Lupus Erythematosus.

Authors:  Dimitrios Mougiakakos; Gerhard Krönke; Simon Völkl; Sascha Kretschmann; Michael Aigner; Soraya Kharboutli; Sebastian Böltz; Bernhard Manger; Andreas Mackensen; Georg Schett
Journal:  N Engl J Med       Date:  2021-08-05       Impact factor: 91.245

5.  The proteasome inhibitior bortezomib depletes plasma cells and ameliorates clinical manifestations of refractory systemic lupus erythematosus.

Authors:  Tobias Alexander; Ramona Sarfert; Jens Klotsche; Anja A Kühl; Andrea Rubbert-Roth; Hannes-Martin Lorenz; Jürgen Rech; Bimba F Hoyer; Qingyu Cheng; Aderajew Waka; Adriano Taddeo; Michael Wiesener; Georg Schett; Gerd-Rüdiger Burmester; Andreas Radbruch; Falk Hiepe; Reinhard E Voll
Journal:  Ann Rheum Dis       Date:  2015-02-20       Impact factor: 19.103
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.